SAN CARLOS, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Nektar Therapeutics'
(Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is
scheduled to present at the upcoming 27th Annual J.P. Morgan Healthcare
Conference in San Francisco at the Westin St. Francis Hotel on Tuesday,
January 13, 2009 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time).
The presentation will be accessible via a Webcast through a link posted on
the Investor Relations, Events Calendar section of the Nektar website:
http://www.nektar.com. This Webcast will be available for replay until
February 15, 2009.
About Nektar
Nektar Therapeutics is a biopharmaceutical company developing novel
therapeutics based on its advanced polymer conjugate technology platforms.
Nektar's technology and drug development expertise have enabled nine approved
products for partners, which include leading biopharmaceutical companies.
Nektar is also developing a robust pipeline of its own high-value therapeutics
that addresses unmet medical needs by leveraging and expanding its technology
platforms to improve and enable molecules. For more information on Nektar
Therapeutics, please visit http://www.nektar.com.
Nektar Contacts:
Jennifer Ruddock
Nektar Therapeutics
650-631-4954
jruddock@nektar.com
Susan Noonan
The SAN Group
212-966-3650
susan@sanoonan.com
SOURCE Nektar Therapeutics
